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Nanoemulsified gamma-oryzanol rich fraction blend regulates hepatic cholesterol 
metabolism and cardiovascular disease risk in hypercholesterolaemic rats 
ABSTRACT 
We have reported that a bioactive-rich fraction, called EORY, from a combination of 
supercritical fluid-extracted rice bran oil and palm oil has abundant gamma-oryzanol, 
tocopherols and tocotrienol. Moreover, EORY has balanced composition of 
polyunsaturated:saturated fatty acids, with the potential for hypocholesterolaemic and 
antioxidant effects. However, the bioactive compounds in EORY are lipophilic and therefore 
pose bioavailability problems. This study evaluated the cardioprotective effects of orally-
administered EORY emulsion and its nanoemulsion (NEORY) on diet-induced 
hypercholesterolaemic rats. NEORY reduced body weight gain, heart weight, lipid 
parameters and oxidised LDL, and improved HDL better than EORY and simvastatin. 
NEORY also significantly increased hepatic mRNA expression of HMGCoA reductase, 
apolipoprotein A1 and LDLR, and lowered apolipoprotein B and LPL. The effects of 
NEORY on lipid parameters, lipid peroxidation markers and hepatic cholesterol metabolism 
suggested that it could regulate the risk of cardiovascular disease, possibly due to increased 
absorption of gamma-oryzanol, tocopherols and tocotrienol. 
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